Loading clinical trials...
Loading clinical trials...
Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis
Conditions
Interventions
fludarabine phosphate
Mycophenolic Acid
+8 more
Locations
2
United States
Colorado Blood Cancer Institute
Denver, Colorado, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
September 1, 2006
Primary Completion Date
November 1, 2011
Completion Date
August 1, 2017
Last Updated
June 4, 2018
NCT07090226
NCT07326033
NCT06722105
NCT00379431
NCT03508375
NCT03629002
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions